Walter Jonat
Arnold Heller Str. 3
Kiel, SH 24105, Germany
Kiel, SH 24105, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 03, 2018
Influence of physical activity on the immune system in breast cancer patients during chemotherapy.
Journal: Journal of cancer research and clinical oncology
Published: November 20, 2017
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: February 06, 2017
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 24, 2017
Influence of arm crank ergometry on development of lymphedema in breast cancer patients after axillary dissection: A randomized controlled trail.
Journal: Journal of rehabilitation medicine
Published: January 20, 2017
Feasibility study to evaluate compliance of physical activity over a long time period and its influence on the total activity score, glucose metabolism and physical and psychological parameters following breast cancer.
Journal: Molecular and clinical oncology
Published: February 03, 2016
Comparing Endurance and Resistance Training with Standard Care during Chemotherapy for Patients with Primary Breast Cancer.
Journal: Anticancer research
Published: September 27, 2015
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer.
Journal: International journal of clinical oncology
Published: June 26, 2015
Vulvar cancer: epidemiology, clinical presentation, and management options.
Journal: International journal of women's health
Published: April 08, 2015
Interdisciplinary Diagnosis and Treatment of Deep Infiltrating Endometriosis
Journal: Zentralblatt fur Chirurgie
Published: February 28, 2015
TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.
Journal: Oncotarget
Published: October 02, 2014
Last Updated: 09/26/2026